Astrazeneca hits the roof
By
Research Desk
about 11 years ago
Astrazeneca Pharma had declared its numbers yesterday just 4 minutes before market close and today, the stock has rightly reacted to it. The stock is frozen on the upper circuit of 20% at Rs.885.75 with volumes up more than 10 times at around 90,000 shares compared to around 9000 shares over past two weeks average.
The company turned around in Q1FY14 with a net profit of Rs 1.77 crore v/s loss of Rs.8.15 crore in Q1Fy13 and a much bigger loss of Rs.18.57 crore in Q4. This bounce back was on robust topline, which rose 37% (QOQ) at Rs.125 crore.